Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling

• Published in: Inflammatory bowel diseases Vol. 28; no. 1; pp. 96 - 108
• Main Authors: Gong, Lingqi, Xiao, Jintao, Yi, Jun, Xiao, Junbo, Lu, Fanggen, Liu, Xiaowei
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 05.01.2022
• Subjects: Animals; Crohn Disease - metabolism; Crohn's disease; Exosomes - metabolism; Humans; Inflammatory bowel disease; Macrophages - metabolism; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Pathogenesis; Toll-Like Receptor 4 - metabolism; Crohn disease; microRNA; macrophages; exosomes
• DOI: 10.1093/ibd/izab132
• ISSN: 1078-0998; 1536-4844

Abstract Background Exosomes are extensively reported to be strongly associated with many immunologic diseases, including Crohn disease (CD). Meanwhile, the dysfunction of macrophage activation has been proposed to be critical for the pathogenesis of CD. However, it is an unsettled issue whether serum exosomes from CD could activate macrophages and participate in its pathogenesis. Our study intended to clarify the role of CD-derived exosomes on macrophages to elucidate a novel mechanism and possible diagnostic and therapeutic strategies. Methods Serum exosomes were isolated and identified. Functional assays in vitro were performed on Raw264.7 macrophages, followed by exosomal microRNA (miRNA) profiling and bioinformatics analyses via high-throughput sequencing. In animal experiments, exosomes were intraperitoneally injected into dextran sulfate sodium–induced colitis. Results In vitro CD-derived exosomes induced proinflammatory cytokine expression and increased macrophage counts. Meanwhile, the intervention of exosomes from CD with epithelial cells led to increased permeability of the intestinal epithelial barrier. In vivo, CD-derived exosomes could circulate into the intestinal mucosa and significantly aggravate colitis. Furthermore, CD changed the miRNA profile of exosomes and further analysis revealed a differential expression of let-7b-5p. Mechanistically, the let-7b-5p/TLR4 pathway was recognized as a potential contributor to macrophage activation and inflammatory response. Furthermore, serum exosome–mediated let-7b-5p mimic delivery alleviated colitis significantly. Conclusions Our study indicated that serum exosomes can circulate into the intestinal mucosa to aggravate colitis by regulating macrophage activation and epithelial barrier function. In addition, CD showed altered exosomal miRNA profiles. Furthermore, serum exosome–mediated let-7b-5p-mimic delivery may significantly alleviate colitis, providing potential novel insight into an exosome-based strategy for the diagnosis and treatment of CD.